Gabriella Rossi
Overview
Explore the profile of Gabriella Rossi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giacopuzzi S, Torroni L, Bencivenga M, Weindelmayer J, Gervasi M, Verlato G, et al.
Dig Surg
. 2023 Jan;
40(1-2):21-30.
PMID: 36696890
Introduction: RCTs support neoadjuvant chemoradiotherapy (nCRT) followed by surgery in locally advanced esophago-gastric junction (LA-EGJ) adenocarcinoma. However, RCTs are performed in highly controlled settings with limited representativeness of real-life patients...
2.
Jonsson M, Scheffel J, Larsson E, Moller M, Rossi G, Lundqvist M, et al.
N Biotechnol
. 2022 Nov;
72:159-167.
PMID: 36450334
Protein activity regulated by interactions with metal ions can be utilized for many different purposes, including biological therapies and bioprocessing, among others. Calcium ions are known to interact with the...
3.
Simoni N, Rossi G, Cellini F, Vitolo V, Orlandi E, Valentini V, et al.
Life (Basel)
. 2022 Apr;
12(4).
PMID: 35454956
Locally advanced pancreatic cancer (LAPC) represents a major urgency in oncology. Due to the massive involvement of the peripancreatic vessels, a curative-intent surgery is generally precluded. Historically, LAPC has been...
4.
Rossi G, Altabella L, Simoni N, Benetti G, Rossi R, Venezia M, et al.
World J Gastrointest Oncol
. 2022 Mar;
14(3):703-715.
PMID: 35321278
Background: Surgical resection after neoadjuvant treatment is the main driver for improved survival in locally advanced pancreatic cancer (LAPC). However, the diagnostic performance of computed tomography (CT) imaging to evaluate...
5.
Palazzo L, Pompele S, Rossi M, Rossi G, Spinoglio S, Testoni I
Pastoral Psychol
. 2022 Feb;
71(2):217-231.
PMID: 35132281
Several researches in scientific literature analyze the theme of Muscular Dystrophy (MD), As well as many others focus on the theme of the Covid-19 pandemic; however, there is a rather...
6.
Testoni I, Palazzo L, Ronconi L, Rossi G, Ferizoviku J, Morales J
Sci Rep
. 2021 Aug;
11(1):16046.
PMID: 34362966
Children that have a parent with Amyotrophic Lateral Sclerosis (ALS) suffer from the progressive loss of their beloved ones. During the COVID-19 pandemic, the difficulties faced by these children have...
7.
Cernusco N, Del Bianco P, Romano M, Muraglia A, Rossi G, Giri M, et al.
Clin Breast Cancer
. 2021 Jul;
22(2):e167-e172.
PMID: 34257000
Methods And Materials: From July 2006 to December 2015, 295 patients suitable for breast-conserving therapy entered a single-arm phase II study and were treated with IOERT as radical treatment. Inclusion...
8.
Rossi G, Simoni N, Paiella S, Rossi R, Venezia M, Micera R, et al.
Front Oncol
. 2021 May;
11:662205.
PMID: 33959509
Background And Objective: To assess the efficacy of a Risk-Adapted Ablative Radiotherapy (RAdAR) approach, after intensive induction chemotherapy, in patients with locally advanced pancreatic cancer (LAPC). Material And Methods: Patients...
9.
Testoni I, Palazzo L, Calamara N, Rossi G, Wieser M
Behav Sci (Basel)
. 2021 Jan;
11(1).
PMID: 33419214
The study presents the results of qualitative research carried out within a death education project dedicated to advance treatment directives (ATDs) in which it was proposed to participants to empathize...
10.
Mazzarotto R, Simoni N, Guariglia S, Rossi G, Micera R, De Robertis R, et al.
Front Oncol
. 2021 Jan;
10:600940.
PMID: 33392093
Background And Objective: To assess the dosimetric feasibility of a stereotactic body radiotherapy (SBRT) dose escalated protocol, with a simultaneous integrated boost (SIB) and a simultaneous integrated protection (SIP) approach,...